Plasma Protein Levels and Very Preterm Birth
ProHémie
Early Plasma Protein Levels and Neonatal Hemodynamics: a Prospective Evaluation in Very Preterm Infants
2 other identifiers
observational
125
1 country
2
Brief Summary
The primary aim of this study is to investigate the relationship between early plasma protein levels and hemodynamics in very preterm infants during postnatal transition. Secondary aims are the following: i) to evaluate maternal and neonatal factors affecting plasma protein level at birth; ii) to evaluate the relationship between plasma protein level and albumin level on the first day of life; iii) to evaluate the association between early hypoproteinemia and neonatal mortality and morbidity in very preterm infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2014
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 25, 2013
CompletedFirst Posted
Study publicly available on registry
December 11, 2013
CompletedStudy Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedOctober 1, 2018
September 1, 2018
1.2 years
November 25, 2013
September 28, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evidence of clinical hemodynamic disturbances defined by arterial hypotension (non-invasive measure of MAP - mmHg - pathological for gestational age) or measured at organ colour doppler, echocardiography or NIRS
about 6 hours after birth
Secondary Outcomes (3)
plasma protein
at 1 second after birth (cord blood sample)
Albumin level
At 12 hours after birth
Mortality rate
patients will be followed for the duration of hospital stay, that is an average of 8 weeks
Study Arms (1)
Very preterm babies
Observational model: cohort
Interventions
* Patient inclusion at birth * Total plasma protein values measurement on cord blood sample at birth * Hemodynamic evaluation at 6 hours after birth with colour doppler echocardiography and organ blood flow colour doppler * Total plasma protein and albumin values measurement on plasma sample at 12 hours after birth * Blood pressure, heart rate, O2 saturation, capillary refill time, rSO2 \[regional (cerebral and somatic) tissue oxygenation by NIRS - near infrared spectroscopy\] will be monitored over 24 hours after birth.
Eligibility Criteria
Very preterm infants with birth at less than 32 weeks of gestational age
You may qualify if:
- Parents written informed consent
- Birth at less than 32 weeks of gestational age
- Birth in a III level delivery facility at Reunion Island
You may not qualify if:
- Major congenital abnormalities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre Hopsitalier Universitaire de La Réunion
Saint-Denis, La Réunion, 97405, France
Centre Hospitalier de La Réunion
Saint-Pierre, La Réunion, 97448, France
Study Officials
- PRINCIPAL INVESTIGATOR
Silvia Iacobelli
CHU de La Réunion -Site du GHSR
- PRINCIPAL INVESTIGATOR
Sylvain Samperiz, MD
CHU de La Réunion - Hôpital Félix Guyon
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 25, 2013
First Posted
December 11, 2013
Study Start
January 1, 2014
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
October 1, 2018
Record last verified: 2018-09